Finasteride/Tamsulosin

非那雄胺/坦洛新

Report date: 2025/07/29 14:30:26

Base Information

Drug NameFinasteride/Tamsulosin
Drug Alias NameTamsulosin/Finasteride坦洛新非那雄胺坦洛新/非那雄胺Tamsulosin and Finasteride非那雄胺坦洛新 +[7] 
ClassificationSmall molecules
Mechanisms of ActionSteroid 5 alpha reductase inhibitorsAlpha-1a adrenergic receptor antagonists
TargetsSteroid 5 alpha reductaseAlpha-1a adrenergic receptor
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes Tamsulosin HydrochlorideFinasteride
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGl Pharmtech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGl Pharmtech
Active IndicationsN/A
Inactive IndicationsProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A